Cells take up long chain free fatty acids (FFA) in vivo from the non-protei
n bound ligand pools in extracellular fluid and plasma, which contain simil
ar to 100 and 600 mu M albumin, respectively. The physiologic range of unbo
und FFA concentrations in such fluids has traditionally been calculated at
< 1 mu M. Studies of I:[H-3]-oleate uptake by hepatocytes, adipocytes, card
iac myocytes and other cell types demonstrate that FFA uptake within this r
ange is saturable, and exhibits many other kinetic properties indicative of
facilitated transport. Within this range, the uptake kinetics of the acidi
c (pKa = 0.5) FFA analog alpha(2)beta(2)omega(3)-heptafluorostearate are si
milar to those of stearate. Thus, uptake of physiologic concentrations of F
FA involves facilitated transport of the FFA anion (FA(-)). Over a much wid
er range of unbound FFA concentrations hepatocellular [H-3] -oleate uptake
exhibits both saturable and non-saturable components. Oleate binding to liv
er plasma membranes (LPM) also demonstrates such components. Comparing the
two components of FFA uptake to the corresponding components of binding per
mits estimates of trans-membrane transport rates. T-1/2 for saturable uptak
e (similar to 1 sec) is less than for non-saturable uptake (similar to 14 s
ec). Others have determined the flip-flop rates of protonated FFA (FAH) acr
oss small and large unilamellar vesicles (SUV, LUV) and across cellular pla
sma membranes. These reported flip-flop rates, measured by the decrease in
pH resulting from the accompanying proton flux, exhibit a highly significan
t inverse correlation with cell and vesicle diameter (r = 0.99). Although T
-1/2's in vesicles are in the msec range, those in cells are > 10 sec, and
thus comparable to the rates of non-saturable uptake we determined. Thus, u
nder physiologic conditions, the predominant mechanism of cellular FFA upta
ke is facilitated transport of FA(-); at much higher, non-physiologic FFA c
oncentrations, passive flip-flop of FAH predominates. Several plasma membra
ne proteins have been identified as potential mediators of facilitated FFA
transport. Studies in animal models of obesity and non-insulin dependent di
abetes mellitus demonstrate that tissue-specific regulation of facilitated
FFA transport has important pathophysiologic consequences.